What should I pay attention to before and after taking pemetinib? Analysis of the effects of diet and other drugs

Before using pemigatinib (Pemigatinib), patients need to undergo a detailed physical examination and evaluation to ensure that the drug is suitable for their condition. First, patients should inform their doctor if they have abnormal liver function, kidney function problems, or other important health problems, as these problems may affect the metabolism and excretion of the drug. In addition, the use of pemetinib may cause electrolyte disorders, especially low potassium, low phosphorus, and low calcium. Therefore, patients need to have their electrolyte levels evaluated before treatment.

Patients need to pay attention to their diet when taking pemetinib. Since pemetinib will affect the electrolyte balance in the body, it is recommended that patients appropriately increase foods containing potassium, calcium and phosphorus, such as bananas, oranges, dairy products and green vegetables, during the medication period to help maintain normal levels of electrolytes. In addition, patients should avoid eating too much high-fat food, because high-fat diet may affect the absorption of the drug, thus affecting the efficacy. Although there are no clear food taboos, a sensible diet can help reduce the occurrence of side effects.

There may be interactions between pemetinib and some medications. For example, certain drugs may affect the metabolism of pemetinib, causing the blood concentration to increase or decrease. Especially when combined with strong CYP3A4 inhibitors (such as ketoconazole, itritinib, etc.), it may increase the plasma concentration of pemetinib and increase the risk of side effects. Therefore, patients should avoid concomitant use with strong CYP3A4 inhibitors while taking pemetinib. If use is necessary, the dose of pemetinib may need to be adjusted.

In addition, when using pemetinib, care should be taken to avoid combined use with potent CYP3A4 inducers (such as carbamazepine, phenobarbital, etc.), because these drugs may accelerate the metabolism of pemetinib, resulting in reduced efficacy. Patients should communicate with their doctor before taking medication to confirm other medications they are taking to adjust their treatment plan.

Reference materials:https://go.drugbank.com/drugs/DB15102